Search PDMR transactions

Notifier
Name of person with notification obligation
Lars Öhman
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Lars Öhman
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Kubator Therapeutics AB
Issuer´s LEI code
549300X78DIFIQ65Z975
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Lipigon Pharmaceuticals AB TO3 SE0019914102 Exercise decrease 171,600 Quantity 0.20 SEK 30/05/2024 Outside a trading venue
Share Lipigon Pharmaceuticals SE0015382072 Exercise increase 171,600 Quantity 0.30 SEK 30/05/2024 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals AB TO3 SE0019914102 Exercise decrease 30/05/2024 Outside a trading venue 171,600 (Quantity) 0.20 SEK
Lipigon Pharmaceuticals SE0015382072 Exercise increase 30/05/2024 Outside a trading venue 171,600 (Quantity) 0.30 SEK
<< Back